The treatment costs for most studies are generally considered part of normal cancer care and are billed to the participant’s insurance carrier; however, expenses not covered by insurance or Medicare may be billed to the participant. The study organizers may pay for certain experimental drugs or procedures. Participants should discuss these issues with their doctor.